What is the ticker symbol for Longeveron?

Longeveron trades under the ticker LGVN on NASDAQ.

What sector does Longeveron operate in?

Longeveron is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze LGVN in a portfolio?

PortView shows LGVN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Longeveron (LGVN) Stock Analysis

NASDAQHealthcareBiotechnology

$6.71-0.59%

1-year price historyRange $4.84 – $11.60

52-week range$6.71

$4.75$12.30

What Longeveron does

Longeveron Inc. is a biotechnology company currently in the clinical development stage, dedicated to pioneering cell-based therapies. These treatments are designed to address both age-related conditions and various critical, life-threatening illnesses. The company's primary investigational product is LOMECEL-B, a sophisticated cellular therapy. This product is created from medicinal signaling cells that are cultivated and expanded after being harvested from the bone marrow of healthy young adult donors. Longeveron is actively conducting Phase 1 and Phase 2 clinical trials to evaluate LOMECEL-B's potential across a diverse range of indications. These include age-related frailty, Alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome (ARDS), and hypoplastic left heart syndrome (HLHS). Established in 2014, Longeveron Inc. operates from its headquarters in Miami, Florida.

Key metrics

Market cap

$20.42M

P/E (TTM)

-6.78

EPS (TTM)

$-0.99

Beta

-0.25

Dividend yield

0.00%

Revenue / share

$0.38

50-day avg

$6.96

200-day avg

$7.20

52-week high

$12.30

52-week low

$4.75

CEO

Stephen H. Willard

ETFs linked to LGVN

Broad-market and Healthcare sector ETFs an investor holding Longeveron is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how LGVN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze LGVN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Longeveron?: Longeveron trades under the ticker LGVN on NASDAQ.
Which exchange is LGVN listed on?: LGVN is listed on NASDAQ.
What sector does Longeveron operate in?: Longeveron is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze LGVN in a portfolio?: PortView shows LGVN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.